Similar articles

• [Evaluation of the treatment of chronic active hepatitis (HBsAg+) with isoprinosine. II. Immunological studies].

  Dabrowska-Bernstein B, Stasiak A, Dabrowski M, Pawińska A, Cianciara J, Loch T, Babiuch L. Dabrowska-Bernstein B, et al. Pol Tyg Lek. 1990 Apr 16-30;45(16-18):347-51. Pol Tyg Lek. 1990. PMID: 1700402 Clinical Trial. Polish.
• Isoprinosine in the treatment of chronic active hepatitis type B.

  Cianciara J, Laskus T, Gabinska E, Loch T. Cianciara J, et al. Scand J Infect Dis. 1990;22(6):645-8. doi: 10.3109/00365549009027115. Scand J Infect Dis. 1990. PMID: 1704640
• [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].

  Maier KP, Lepiorz H, Berthold H, Gerok W. Maier KP, et al. Leber Magen Darm. 1982 Aug;12(4):150-3. Leber Magen Darm. 1982. PMID: 7132529 German.
• [Interferon is useful in the treatment of chronic hepatitis B].

  Vuoristo M. Vuoristo M. Duodecim. 1991;107(13):1087-90. Duodecim. 1991. PMID: 1365335 Review. Finnish. No abstract available.
• [Clinical aspects and epidemiology of hepatitis B].

  Gerken G, Meyer zum Büschenfelde KH. Gerken G, et al. Z Arztl Fortbild (Jena). 1992 Jun 25;86(12):589-93. Z Arztl Fortbild (Jena). 1992. PMID: 1636264 Review. German. No abstract available.